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Abstract 
The specific neurochemical substrate underlying the amnesia in patients with Wernicke-
Korsakoff syndrome (WKS) is still poorly defined. Memory impairment has been linked to 
dysfunction of neurons in the cholinergic system. A transcranial magnetic stimulation (TMS) 
protocol, the short latency afferent inhibition (SAI), may give direct information about the 
function of some cholinergic pathways in the human motor cortex. In the present study we 
measured SAI in eight alcoholics with WKS and compared the data with those from a group 
of age-matched healthy individuals; furthermore, we correlated the individual SAI values of 
the WKS patients with memory and other cognitive functions. Mean SAI was significantly 
reduced in WKS patients when compared with the controls. The low score obtained in the 
Rey Complex Figure delayed recall test, the Digit Span subtest of the Wechsler Adult 
Intelligence Scale – Revised (WAIS-R) and the Corsi's Block Span subtest of the WAIS-R 
documented a severe impairment in the anterograde memory and short-term memory. None of 
the correlations between SAI values and these neuropsychological tests reached significance. 
We provide physiological evidence of cholinergic involvement in WKS. However, this 
putative marker of central cholinergic activity did not correlate positively with the memory 
deficit in our patients. These findings suggest that the cholinergic dysfunction does not 
account for the memory disorder and damage to the cholinergic system is not sufficient to
 
cause a persisting amnesic syndrome in WKS.  
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Introduction 
The Wernicke-Korsakoff syndrome (WKS) is a neuropathological term which encompasses 
two clinical syndromes in thiamine-deficient alcoholics and non-alcoholics, Wernicke 
encephalopathy and the associated amnesic syndrome, Korsakoff psychosis. Wernicke 
encephalopathy is characterised by eye and gait disorders and mental confusion, and can lead 
to the profound and permanent amnesia known as Korsakoff psychosis. The clinical diagnosis 
of Korsakoff psychosis has only recently standardized with the clinical amnesic syndrome 
characterized by persistent anterograde memory loss and preserved semantic memory, 
intelligence and learned behaviour (Kopelman 1995; Caine et al. 1997). 
Although there are several comprehensive descriptions of the neuropathology of Wernicke 
encephalopathy (Victor et al. 1989; Harper and Kril 1990) the specific neural substrate 
underlying the amnesia in WKS is also poorly defined. Central cholinergic mechanisms have 
been implicated in cortical activation and memory. The basal forebrain cholinergic neurons 
(BFCNs) provide the major cholinergic input to hippocampal and cortical regions and are 
believed to modulate cognitive and attentional processes (Kasa et al. 1997; Bartus 2000). 
Cell
 
counting has shown that WKS could
 
be associated with a reduction of BFCNs,
 
including 
the nucleus basalis of Meynert, the major source of
 
cortical acetylcholine (Ach) (Arendt et al. 
1988). Mayes and co-workers (1998) made morphometric measurements of BFCNs of two 
cases of WKS; in both cases,
 
the post-mortem study showed a decrease in the number or 
nucleolar
 
volume of magnocellular neurons in the nucleus basalis of Meynert. However, 
although cholinergic involvement in the amnesic syndrome is widely cited in the literature on 
WKS, the studies
 
supporting the hypothesis have lacked appropriate controls (Arendt et al. 
1988, 1995). A neuro.pathologic study showed that cell loss in the cholinergic nucleus basalis 
is minor (Cullen et al. 1997). Whereas neurons in the nucleus basalis are at risk in thiamine 
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deficient alcoholic patients, cell loss is minor and does not
 
account for the profound memory
 
disorder. 
Thus, the current evidence from post-mortem and in vivo studies on cholinergic involvement 
in WKS was inconclusive. Also treatments for WKS
 
remain elusive and the role of the 
cholinergic system in WKS needs to be further investigated in view of implications for 
treatment with cholinergic agents. It is well established that acetylcholinesterase (AchE) 
inhibitors offer
 
a partial benefit in Alzheimer's dementia (AD) and other dementias
 
characterized by memory deficit. Theoretically,
 
AchE inhibitors might similarly prove to be
 
at 
least partially useful in WKS.
 
Kopelman and Corn (1998) investigated the effect of 
cholinergic
 
blockade on a spectrum of memory functions and found a pattern
 
of deficit that 
corresponded more closely to that seen in WKS than that in AD. Some case reports of 
alcohol-related
 
WKS treated with AchE (Angunawela and Barker 2001; Cochrane et al. 2005) 
suggested promising results.
 
However, another study of donepezil in the treatment of seven 
patients with
 
non-alcoholic WKS (Sahin et al. 2002) showed no benefit over placebo, and 
recently Luykx and colleagues (2008) reported that rivastigmine may not be effective in 
restoring memory in WKS patients.  
In vivo demonstration of cholinergic deficit in AD and other dementias was recently provided 
using a transcranial magnetic stimulation (TMS) technique that may held information about 
the function of some cholinergic circuits in the human brain (Di Lazzaro et al. 2002, 2006; 
Nardone et al. 2006; Manganelli et al. 2008) This technique relies on short latency afferent 
inhibition (SAI) of the motor cortex (Tokimura et al. 2000).  
The present study examined SAI in patients with WKS; furthermore, we correlated this 
putative marker of central cholinergic activity with memory and other cognitive functions.  
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Materials and methods 
Patients 
The study included eight patients (six men and two women, mean age 54.4  years, range 35-
62) with alcohol induced persisting amnesic disorder (WKS; DMS-IV) (American Psychiatric 
Association, 1994) and 10 age-matched neurologically healthy controls (eight men and two 
women, mean age 53.0 years, range 33-65 years). Seven patients and nine control subjects 
were right-handed. 
At the time of neurophysiological examination, MRI was unremarkable in two patients and 
showed atrophy of the mammillary bodies in six patients. Patients with brain lesions 
involving brain regions other than the mammillary bodies were excluded from the study. 
Exclusion criteria also included: evidence of concomitant dementia such as AD, 
frontotemporal, vascular, or reversible dementias; evidence of concomitant extra-pyramidal 
symptoms; evidence of depression; other psychiatric diseases, epilepsy, drug addiction; 
current or previous uncontrolled or complicated systemic diseases or traumatic brain injuries.  
Nerve conduction studies excluded peripheral neuropathies in all patients. All the selected 
WKS patients were able to understand and carry out the simple tasks required for this 
electrophysiological study, such as to contract a hand muscle or to keep fully relaxed. 
None of the patients were treated with anticholinergic drugs before the study. Administration 
of all drugs that affect motor cortex excitability in patients and control subjects was 
discontinued at least two weeks before the study. 
A neuropsychological examination was performed between 8 weeks and 3 months after onset 
of the disease using the following tests: the Mini-Mental State Examination (MMSE), the Rey 
Complex Figure, the Wechsler Adult Intelligence Scale (WAIS) Information subtest, the Digit 
Span subtest of the WAIS – revised (WAIS-R), the Corsi's Block Span subtest of the WAIS-R 
and the Gollin Incomplete Pictures Test. 
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The main demographic characteristics and the performance of each patient on these 
neuropsychological tests are reported in the Table 1. The global level of cognitive functions 
was slight reduced or within the normal range. As expected, the poor performances on the 
Rey Complex Figure delayed recall test, on the WAIS-R Digit Span and Corsi's Block Span 
subtests revealed a severe impairment of anterograde episodic memory, short-term verbal 
memory and short term visual/spatial memory. The good performance in the immediate recall 
test on the Rey Complex Figure indicates a relative preservation of visuospatial/constructional 
abilities and the good performance on the Gollin test could be explained by the preservation 
of immediate and non-declarative memory. The semantic memory storage was also preserved, 
as proved by the score obtained in the WAIS Information subtest.  
Patients provided informed consent before participation in this study, which was performed 
according the Declaration of Helsinki and approved by the institutional Ethics Committee. 
 
Transcranial magnetic stimulation 
TMS was performed using a High-power Magstim 200 magnetic stimulator (Magstim Co., 
Whitland, Dyfed, UK). A figure-of-eight coil with external loop diameters of  9 cm was held 
over the motor cortex at the optimum scalp position to elicit motor responses in the first 
dorsal interosseous (FDI) muscle. The dominant hemisphere was selected for stimulating 
patients and healthy subjects. The induced current flow in a postero-anterior direction. MEPs 
were recorded via two 9 mm diameter Ag-AgCl electrodes with the active electrode applied 
over the motor point of the muscle and the reference on the metacarpophalangeal joint of the 
index finger. MEPs were amplified and filtered (bandwidth 3-3000 Hz) by D150 amplifiers 
(Digitimer, Welwyn Garden City, Herfordshire, UK). 
SAI was studied using the recently described technique (Tokimura et al. 2000).  
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Conditioning stimuli were single pulses (200 µs) of electrical stimulation (with the cathode 
positioned proximally) applied through bipolar electrodes to the median nerve at the wrist. 
The intensity of the conditioning stimuli was set at just over motor threshold for evoking a 
visible twitch of the thenar muscles. The intensity of the test cortical magnetic shock was 
adjusted to evoke a muscle response in relaxed FDI with an amplitude of approximately 1mV 
peak-to-peak. The conditioning stimulus to the peripheral nerve preceded the test magnetic 
cortical stimulus. Interstimulus intervals (ISIs) were determined relative to the latency of the 
N20 component of the somatosensory evoked potential evoked by stimulation of the median 
nerve. The active electrode for recording the N20 potential was attached 3 cm posterior to C3 
(10-20 system), and the reference was 3 cm posterior to C4. Five hundred responses were 
averaged to identify the latency of N20 peak. ISIs from the latency of the N20 component 
plus 2 ms to the latency of the N20 component plus 8 milliseconds were investigated in steps 
of 1 ms.  
Five repeats were delivered for cortical magnetic stimulation alone and for conditioned 
stimulation at each ISI in pseudo-randomised order. The amplitude of the conditioned MEP 
was expressed as a percentage of the amplitude of the test MEP. The percentage inhibition of 
the conditioned responses at the seven different ISIs was averaged to obtain a grand mean of 
SAI. Subjects were given audio-visual feedback at high gain to assist in maintaining complete 
relaxation.  
In addition to SAI, we evaluated the following TMS parameters: the resting and active motor 
threshold of MEP; the central motor conduction time (CMCT); the short latency intracortical 
inhibition (SICI) and intracortical facilitation (ICF) to paired TMS.  
Resting motor threshold (RMT) was defined as the minimum stimulus intensity that produced 
a liminal motor evoked response (about 50 µV in 50% of 10 trials) at rest. Active motor 
threshold (AMT) was defined as the minimum stimulus intensity that produced a liminal 
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motor evoked response (about 200 µV in 50% of 10 trials) during isometric contraction of the 
tested muscle at about 10% maximum.  
Central motor conduction was calculated by subtracting the peripheral conduction time from 
spinal cord to muscles from the latency of responses evoked by cortical stimulation with the 
formula: MEP latency – (F latency + M latency – 1)/2 (Rossini et al. 1994). 
Intracortical inhibition and facilitation were studied using the technique of Kujirai et al. 
(1993). 
Using a Bistim module, two magnetic stimuli were given through the same stimulating coil 
over the motor cortex and the effect of the first (conditioning) stimulus on the second (test) 
stimulus was investigated. The conditioning stimulus was set to 90% AMT. The second, test, 
shock intensity was adjusted to evoke a muscle response in relaxed FDI with an amplitude of 
approximately 1 mV, peak-to-peak.  
The timing of the conditioning shock was altered in relation to the test shock. Inhibitory 
interstimulus intervals (ISIs) of 3 ms and facilitatory ISIs of 10 ms were investigated. The 
amplitudes of motor evoked potentials evoked by single stimuli were comparable. Ten stimuli 
were delivered at each ISI. For these recordings, muscle relaxation is very important and the 
subject was given audiovisual feedback at high gain to assist in maintaining complete 
relaxation. The presentation of conditioned and unconditioned trials was randomised. The 
amplitude of the conditioned EMG responses was expressed as the percentage of the 
amplitude of the test EMG responses. The amplitude of the conditioned responses were 
averaged obtaining grand mean amplitudes of the inhibitory and of the facilitatory ISIs.  
To clarify a possible spinal or peripheral contribution on the motor cortex excitability 
parameters, supramaximal stimulation (0.2-milliseconds square-wave constant current 
pulsies) of the ulnar nerve at the wrist was used to assess spinal and peripheral motor 
excitability. While FDI was relaxed, the peak-to-peak amplitude of F waves (average, 20 
trials) and CMAP (maximum, 3 trials) were determined.  
 9 
 
Statistical analysis 
The electrophysiological parameters of the WKS patients were analysed separately and 
compared with those of the control subjects by means of Mann–Whitney tests. The level of 
significance was set at 0.05.  
The relation between different variables, including the statistical comparison between the SAI 
and the 8 examined neuropsychological response measures, were performed by using the 
Spearman rank correlation and the Pearson product moment correlation coefficients. 
 
 
Results 
The neurophysiological data are summarized in the Table 2. 
The mean amount of SAI was significantly smaller in the WKS patients (mean responses 
reduced to 64.3 % ± 14.2  of test size) than in normal controls (mean responses reduced to 
44.7 % ± 9.4 %  of test size; P < 0.05, Mann–Whitney test, N 1 = 8, N 2 = 10).  
RMT, AMT, CMCT, SICI and ICF did not differ significantly between WKS subjects and 
control subjects (P > 0.05, Mann–Whitney test, N 1 = 8, N 2 = 10).  
SAI showed a significant correlation only with the WAIS Information subtest (Pearson's 
correlation coefficient equal to -0.6); there were no positive correlations between SAI and the 
remaining neuropsychological tests performed (Table 3). Moreover, SAI did not correlate 
significantly with age, sex, and presence or absence of mammillary bodies atrophy (P > 0.01; 
Spearman’s r). 
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Discussion 
We first demonstrated excitability changes in those cholinergic cortical networks that are 
involved in SAI in patients with WKS. The number of patients with abnormal SAI 
conceivably reflects the percentage of subjects with a significant cholinergic dysfunction 
among the patients with a clinical diagnosis of WKS.  
The common factor
 
underlying the development of WKS syndrome
 
is almost certainly due to 
depletion of thiamine. It has been
 
reported that thiamine deficiency may damage the 
cholinergic
 
system as a result of a complex interaction between cellular,
 
neurochemical and 
metabolic properties (Witt, 1985). Thiamine pyrophosphate
 
(TPP), the active form of 
thiamine, is involved in three enzymatic
 
reactions essential for the metabolism of glucose and 
the production
 
of neurotransmitters, including that of Ach. The inhibition
 
of TPP-dependent 
pyruvate decarboxylase may cause an impairment
 
in the synthesis of Ach (Gibson et al. 1975). 
Moreover,
 
it is reported that cholinergic-rich brain transplants or cholinergic
 
drugs reverse 
alcohol-induced memory deficits in animals (Hodges et al., 1991; Arendt et al. 1995). 
The most salient finding of our study is that SAI deficit did not reflect the severity of 
cognitive dysfunction; in particular, the cholinergic involvement does not seem to be 
correlated with the severity of memory disturbances.  
Therefore, we provide further evidence that the correlation between the decrease in 
cholinergic function and the cognitive decline is not as clearcut as has been assumed.  
Overall, the notion that Ach plays a pivotal role in learning and memory processes is likely to 
be overstated. The cholinergic nucleus basalis is an exclusive site of neurofibrillary 
degeneration in thiamine deficient alcoholic patients (Cullen et al. 1997) but could have a 
more circumscribed role in attention (Voytko et al. 1994; Blockland, 1996). The primate 
cholinergic basal forebrain seems to be more specifically involved in attentional processes 
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than in learning and memory processes. On the other hand, considering the complexity of the 
neuronal networks in the brain, it is unlikely that one neurotransmitter regulates such a 
complex mechanism as learning and memory. It is more realistic to assume an interactive 
framework in which different neurotransmitter systems are involved in these cognitive 
processes. 
Indeed, the literature suggests that excitatory amino acids are more important in the formation 
of memory than Ach, especially glutamate, the most abundant endogenous excitatory amino 
acid in the brain (McEntee and Mair, 1980). Moreover, the (mesotelencephalic) dopaminergic 
system has been proposed to be functionally related to the convergence of information about 
reward (the prefrontal cortex and amygdale) and visual processing and attention (neocortical 
input to striatum) (Dunnett and Robbins, 1992). Noradrenaline, a neurotransmitter localised in 
pathways projecting to the cortex, is also thought to be involved in the process of selective 
attention. Serotonin is another neurotransmitter that has been linked with alcohol dependency. 
Notably, the noradrenergic and serotonergic systems have been implicated
 
in the 
physiological pathway of the Korsakoff syndrome (McEntee and Mair, 1980); indeed, it has 
been reported that fluvoxamine (Martin et al. 1986) and clonidine (Mair et al. 1986) both 
improve the Korsakoff state. 
Furthermore, also the location of the lesion(s) responsible for the amnesia in
 
Korsakoff 
psychosis is not completely known. In addition to the BFCN (Cullen et al. 1997), several 
neuroanatomical regions have been examined in a number of detailed neuropathological 
studies. These regions include the hippocampus (Harding et al. 1997) the dorsolateral 
prefrontal cerebral cortex (Kril et al. 1997) the brainstem serotonergic nuclei (Halliday et al. 
1993) the noradrenergic locus coeruleus (Halliday et al. 1992) and the vasopressin-containing 
neurons in the hypothalamus (Harding et al. 1996). No difference was found between amnesic
 
and non-amnesic alcoholics with WKS in
 
any of these regions. Exclusively the  
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neuronal loss in the
 
anterior thalamic nuclei was found consistently in alcoholic Korsakoff 
psychosis (Harding et al. 2000).  
Taken together, all these findings and the results of the present study do not seem to support a 
critical
 
role for the cholinergic system in memory loss in WKS, and make it difficult to accept 
completely the hypothesis that BFCN degeneration is a necessary prerequisite for the memory 
deficits associated with WKS. Multiple neurochemical abnormalities probably underlie this 
amnesic syndrome; functional interactions between cholinergic and noncholinergic 
neuromodulatory systems that are affected in this disease should be further investigated. 
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